Deutsch

Current Research Projects


-> You can find the complete Status Report 2013-2014 as a PDF file here.


Work Groups and Work Group Leaders (Last Update: 31/10/2014)

AG 1 Epidemiology and Health Services Research
Group Leaders: Prof. Dr. Katja Beesdo-Baum, Dr. Lars Pieper, Prof. Dr. J. Rehm, & Prof. Dr. Hans-Ulrich Wittchen
P1. The Epidemiological Functional and Dysfunctional Behavioral and Psychological Factors in Mental Health and Disease (EBP)
P2. Early Developmental Stages of Psychopathology (EDSP): Natural course, etiology, and pathogenesis of mental and substance use disorders
P3. The German Health Interview and Examination Survey for Adults Mental Health Supplement (DEGS1-MH)
P4. German Health Interview and Examination Survey 1998 Mental Health Supplement (GHS-MHS)
P5. National Survey on Health Care of Depression in German Primary Care Practices (VERA)
P6. Trauma and Stress-related disorders in German Soldiers with and Without Foreign Deployment P7. Mental Disorders in the elderly: Relationship to impairment, functioning (ICF) and service utilisation (MentDis_ICF65+)
AG 2 Experimental Clinical Psychology and Neuroimaging
Group Leaders: PD Dr. Ulrike Lüken, Prof. Dr. Katja Beesdo-Baum, & Dr. Markus Mühlhan
P1. Neuronal plasticity following cognitive-behavioral therapy in patients with panic disorder with agoraphobia: A multicenter 3 Tesla study using fMRI
P2. Neuroimaging markers of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia
P3. Therapygenetics and genetic imaging in panic disorder with agoraphobia
P4. Psychophysiological reactivity during uncertainty and ambiguity processing in high and low worriers
P5. Neural structures, functioning and connectivity in Generalized Anxiety Disorder and interaction with neuroendocrine systems: a systematic review
P6. Neural und endocrine emotion- und stress regulation in generalized anxiety disorder
P7. Differential neuro-biological correlates of emotion- and stress regulation in Generalized Anxiety Disorder compared to Major Depression and Social Phobia
P8. The specificity of neural correlates of generalized anxiety disorder: differentiation from related disorders and prediction of diagnosis using neuroimaging data
P9. Commonalities and differences in fear circuities in subtypes of Specific Phobia
P10. Fear processing in Dental Phobia during crossmodal symptom provocation: an fMRI study
P11. Neural substrates of interoception in the anxiety sensitivity endophenotype
P12. Confounders of neuroimaging investigations: the scanner as a Stressor
P13. Confounders of neuroimaging investigations: The effect of body posture
P14. Experimental psychopathology and research in basic processes of clinical psychological interventions
AG 3 Maternal and Infant's Health
Group Leaders: Dr. Julia Martini & Prof. Dr. Hans-Ulrich Wittchen
P1. Maternal anxiety and depression in relation to infant development (MARI Study)
P2. Mental and physical health in premature infants and their parents
P3. Mental and physical health in parents of chronically ill children<
AG 4 ROAMER - A Roadmap for Mental Health and Well-Being Research in Europe
Group Leaders: Prof. Dr. Hans-Ulrich Wittchen & Dr. Susanne Knappe
P1. Psychological research and treatments state of the art and advances needed
P2. Public mental health research in Europe: A systematic mapping for the ROAMER Project
P3. Clinical research task force Delphi Survey
AG 5 Neuropsychology
Group Leaders: Dr. Oliver Riedel & PD Dr. Ulrike Lüken
P1. GEPAD (German Study on Epidemiology of Parkinson's Disease with Dementia)
P2. Depression bei Parkinson-Erkrankungen (GEPAD)
P3. Depression und Pflegebedürftigkeit bei Parkinson-Patienten (GEPAD)
P4. GEPAD - Sensitivität und Spezifität des Parkinson Neuropsychometric Dementia Assessment (PANDA)
P5. GEPAD Validität des Clock Drawing Test (CDT) bei Parkinson-Patienten mit und ohne Depression
P6. DEMPARK/LANDSCAPE Demenz bei der Parkinson Erkrankung: Eine längsschnittliche Kohortenstudie
P7. DBS-REWARD: Effekte der Tiefen Hirnstimulation des Nucleus subthalamicus auf das Belohnungssystem bei Patienten mit fortgeschrittener Parkinsonerkrankung
P8. fronto-striatale Dysregulation kognitiver und motivationaler Flexibilität bei der Parkinsonerkrankung (FLEXI-PD; SFB 940, Projekt C4)
P9. Dopaminerge Modulation des hippocampal vs. striatal- modulierten räumlichen Lernens bei Parkinsonpatienten (SFB 940 Projekt C4)
AG 6 Addiction Research Unit
Group Leaders: Prof. Dr. Gerhard Bühringer & Dr. Silke Behrendt
P1. Characteristics of developmentally early alcohol use disorder symptom reports: a prospective-longitudinal community study
P2. Relevance of the psychosocial network for the development of pathological gambling (pilot study)
P3. Impulsivity and cognitive control in pathological gambling
P4. Addiction as disorder of volition: Impaired cognitive control functions in nicotine dependence and pathological gambling
P5. Volitional dysfunction in self-control failures and addictive behaviors
P6. Learning and habitization as predictors of the development and maintenance of alcoholism
P7. Complex time-based prospective memory in DSM-V tobacco use disorder
P8. Efficacy of a targeted cognitive-behavioral treatment program for cannabis use disorders (CANDIS I)
P9: Implementation of the program CANDIS targeted treatment for cannabis disorders in German outpatient treatment facilities (CANDIS II)
P10. PREMOS Predictors, Moderators and Outcomes of Substitution Treatment for opioid dependence in Germany
P11. Treatment of substance use disorders in outpatient psychotherapy
P12. Project Elderly: Motivational Enhancement Therapy and Community Reinforcement Approach For Treating Alcohol Problems in the Elderly an international multicenter study
P13. Dissertation Project The importance of resources for the treatment of alcohol use disorders in older adults
P14. Work area 2/ Work package 5 Counting addiction (Prof. Jürgen Rehm)
P15. Work area 3/Work packages 7-9 Determinants of addiction
P16. Work area 4/ Work package 10 Revenues, profits and participants (sub-study on prison interviews)
P17. Work area 5 / Work package 13.1 Theoretical overview of governance views
P18. Dissertation project Predictors of the course of cannabis use and cannabis use disorders
P19. Work area 3 / Work packages 7-9 Transition probabilities between different stages of substance use
P20. Dissertation project Socioeconomic profiles of alcohol-attributable harm in South Africa Towards a science based decision making in health policy for inclusive growth
AG 7 Behavioural Medicine
Group Leaders: Prof. Dr. Hans-Ulrich Witttchen & Dr. Lars Pieper
P7.1. Collaborative Contributions
P7.2. Severe Allergic Asthma: Prevalence and Current Treatment Needs (SAP-NEEDS)
P7.3. IDEA Improving Alzheimer Dementia Treatment: Epidemiological Assessment of Doctors, Patients&; and Caregivers Unmet Needs and Barriers
P7.4. Anxiety increases pressure: studies in the area of tension between anxiety and blood pressure as well as anxiety disorders and hypertension
P7.5. Alcohol dependence in primary and specialist care in Europe (APC)
P7.6. Cardiorenal syndromes (CRS): A Clinical-Epidemiological Survey of Prevalence, Treatment and Care of Patients with Chronic Kidney Disease (CaRe-Survey)
P7.7. Multiple Sclerosis Patients and their Caregivers Psychopathological and General Burden of Disease - MS Caregiver Burden
P7.8. DETECT (Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment): An overview
P7.9. Psychological and Biological Risk Factors of Burnout
AG 8 Eating Disorders
Group Leader: Prof. Dr. Corinna Jacobi
P1. Internet-gestützte Nachsorge für Frauen mit schwerwiegender und chronischer Bulimia nervosa (IN@)
P2. Early detection and intervention of anorexia nervosa
P3. Internet-gestützte Prävention und Frühintervention für junge Frauen mit erhöhtem Risiko der Entwicklung einer Anorexia nervosa
P4. The Integrated Neurobiology of Food Intake, Addiction, and Stress (NeuroFAST), Arbeitspaket: Interrelations between eating disorders and substance use disorders
AG 9 Clinical Research
Group Leaders: Prof. Dr. Jürgen Hoyer & Prof. Dr. Katja Beesdo-Baum
P1 PROTECT-AD: Providing Tools for Effective Care and Treatment of Anxiety Disorders (AD): Outcomes, Mediators and Moderators of Enhanced Extinction Learning
P2 PANIC-NET
P3 Partnership communication and therapist-patient communication in panic disorder with agoraphobia
P4 Short-term psychodynamic psychotherapy (STPP) and cognitive-behavioral therapy (CBT) in social phobia a randomized controlled multicenter study
P5 Patient characteristics predicting attrition and outcome in CBT for social phobia: Results from a large multicenter trial
P6 Transfer of manualized CBT for social phobia into clinical practice (SOPHOPRAX)
P7 Psychoneuroendocrinology of social phobia
P8 Dissociative symptoms in social phobia during a stressful social performance situation
P9 Task Concentration Training vs. Cognitive Behavioral Therapy: A randomized controlled trial for social anxiety disorder with fear of blushing
P10 GAD-Ambulanz
P11 The Role of Pre-treatment Depression for Psychotherapy Outcome in Generalized Anxiety Disorder
P12 Steroid-Hormonlevel im Haar bei Posttraumatischer Belastungsstörung: Untersuchung langfristiger endokriner Veränderungen im Therapieverlauf
P13 Behavioral activation for depression in groups
P14 Gruppentherapie zur Verhaltensaktivierung bei Depressionen - Konzeption einer therapie-unterstützenden App
P15 Everyday experiences and mood changes
P16 Risiken und Nebenwirkungen von Psychotherapie
P17 Sexual abuse of children and adolescents: Aetiology, dunkelfeld research and the consequences for victims
P18 Social anxiety and loneliness in social and sexual online communication with strangers an international study.
AG 10 Diagnostic Issues and Psychometrics
Group Leaders: Prof. Dr. Hans-Ulrich Wittchen, Prof. Dr. Katja Beesdo-Baum, Dr. Susanne Knappe, & Prof. Dr. Jürgen Hoyer
P1. Separation anxiety disorder in adults: Possible changes in DSM-V
P2. A dimensional approach to measuring anxiety for DSM-5
P3. Psychometric properties of the dimensional anxiety scales for DSM-5 in an unselected sample of German treatment seeking patients
P4. Dimensional anxiety scales for DSM-5: Sensitivity to clinical severity
P5. Test and retest reliability and sensitivity to change of the dimensional anxiety scales for DSM-5
P6. Psychometric Properties of the 1-Week Dimensional Anxiety Scales for DSM-5 in a Non-Clinical Student Sample
P7. Limited psychometric properties of the DSM-5 dimensional assessment scales for OCD and PTSD
P8. Development of a measure for the behavioral symptoms of Generalized Anxiety Disorder
P9. Angststrungen im DSM-5. Ein Überblick über Änderungen in Struktur und Inhalt
P10. Measuring Symptoms and Diagnosing Mental Disorders in the Elderly Community: The Test-Retest Reliability of the CIDI65+
P11. Überprüfung der psychometrischen Eigenschaften der deutschen OASIS-Skala (OASIS-D) im Hausarztsektor
P12. Clinical Assessment of Anxiety Disorders
P13. Strategies and challenges for improving the diagnostics of anxiety disorders
P14. Structured clinical interviews for sexual dysfunctions in women and men according to DSM-5
AG 11 Psychotherapy and Intervention Research
Group Leaders: Prof. Dr. Hans-Ulrich Wittchen & Prof. Dr. Jürgen Hoyer
P1. RCT 1: Optimizing extinction using intensified psychological interventions for adult anxiety disorders
P2. RCT 2: Differential impact of parental participation on intensified exposure-based psychological interventions in anxiety disorders in children
P3. Subproject - Behavioral and psychophysiological markers of extinction learning and outcome
P4. Subproject - Neural response and fear circuitry related to extinction learning and outcome
P5. Subproject - (Epi)genetic effects related to extinction learning and outcome
P7. Transfer of exposure-based interventions into the routine provider system